256.03 USD
↘ 2.63 (1.02%)AT CLOSE (03:59 PM EDT)
Johnson & Johnson
JNJNYSE • USD
256.10
↗ 0.07 (0.03%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
256.10
↗ 0.07 (0.03%)
Market: CLOSED
Johnson & Johnson (JNJ) trades at $256.03 per share. There is a divergence between signals — underlying fundamentals rate "Buy" but technical indicators lean "Strong Sell". This is driven by a robust Altman Z-Score, exceptional Return on Equity (24.8%) and a bullish Golden Cross on the moving averages. On valuation, JNJ trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 2, 2026.
Open?$259.38
High?$259.38
Low?$255.12
Prev. Close?$258.66
Volume?11.6M
Avg. Volume?6.5M
VWAP?$256.42
Rel. Volume?1.78x
Bid / Ask
Bid?$255.81 × 100
Ask?$256.20 × 300
Spread?$0.39
Midpoint?$256.01
Valuation & Ratios
Market Cap?617.0B
Shares Out?2.4B
Float?2.4B
Float %?100.0%
P/E Ratio?29.33
P/B Ratio?7.26
EPS?$8.73
Dividend?2.05%
Ex-Dividend?N/A
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
623.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?99
Momentum?69
Short Sent.?78
Piotroski F-Score?5/9Mixed
Altman Z-Score?5.33Safe
Confidence?74%Moderate
Short InterestModerate
Short % of Float?0.88%Low
Short Interest?21.2M
Days to Cover?3.7
Free Float2.4B
Avg Daily Volume5.8M
Settlement Date2026-09-15
Financial Health
Current Ratio?1.09Adequate
Quick Ratio?0.81Weak
Cash Ratio?0.37Low
Debt/Equity?0.58Moderate
ValuationFAIRLY VALUEDvs 9 peers + S&P 500
Score61/100
P/E?29.3FAIR▾
Peers75
S&P36
P/B?7.26FAIR▾
Peers63
S&P26
P/S?6.30FAIR▾
Peers50
S&P20
P/FCF?27.8FAIR▾
Peers50
S&P33
EV/EBITDA?19.1FAIR▾
Peers63
S&P29
EV/Sales?6.59HIGH▾
Peers50
S&P23
Returns & Efficiency
ROE?24.8%STRONG▾
Peers63
S&P74
ROA?10.5%STRONG▾
Peers75
S&P76
Cash Flow & Enterprise
FCF?$22.2B
Enterprise Value?$645.6B
Fundamentals ratios updated end of day